Chapitre C-1 B - Traitement pharmacologique de l’hyperactivité détrusorienne neurologique : drogues intrathécales
Progrès en Urologie, ISSN: 1166-7087, Vol: 17, Issue: 3, Page: 564-567
2007
- 1Citations
- 21Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Chez des patients blessés médullaires intolérants ou résistants au traitement parasympathicolytique, la clonidine intrathécale a été testée. Si l’effet aigu de la clonidine sur les paramètres urodynamiques était satisfaisant, les effets secondaires cardiovasculaires en ont limité l’effet chronique. Par ailleurs le baclofène intrathécal a peu d’effet sur l’hyperactivité vésicale de patients souffrant d’une spasticité d’origine spinale. Mais il peut entrainer une modification de la qualité des érections et une incapacité à obtenir des éjaculations par stimulation vibratoire pénienne.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1166708707923696; http://dx.doi.org/10.1016/s1166-7087(07)92369-6; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=34250870702&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/17622091; https://linkinghub.elsevier.com/retrieve/pii/S1166708707923696; http://linkinghub.elsevier.com/retrieve/pii/S1166708707923696; http://api.elsevier.com/content/article/PII:S1166708707923696?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1166708707923696?httpAccept=text/plain; http://dx.doi.org/10.1016/s1166-7087%2807%2992369-6; https://dx.doi.org/10.1016/s1166-7087%2807%2992369-6
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know